1. The future of new pure antiestrogens in clinical breast cancer

   • Alan E. Wakeling

   15th San Antonio Breast Cancer Symposium — Plenary lecture Pages: 1 - 9

2. Selenium and the risk of postmenopausal breast cancer in the DOM cohort

   • P. A. H. van Noord
   • M. J. Maas
   • C. Collette

   Report Pages: 11 - 19

3. Epidermal growth factor receptor and prognosis in human breast cancer: a prospective study

   • P. G. Koenders
   • L. V. A. M. Beex
   • Th. J. Benraad

   Report Pages: 21 - 27

4. Comparative effect of embryonic mouse fibroblasts (Balb/c-3T3) on the proliferation of hormone-dependent (T-47D) and hormone-independent (MDA-MB-231) human breast cancer cell lines

   • Gerard Chetrite
   • Laurence Delalonde
   • Jorge R. Pasqualini

   Report Pages: 29 - 35

5. Characterization of binding sites for a GnRH-agonist (buserelin) in human breast cancer biopsies and their distribution in relation to tumor parameters

   • Klaus H. Baumann
   • Ludwig Kiesel
   • Benno Runnebaum

   Report Pages: 37 - 46

6. Progesterone receptors in routinely paraffin-embedded primary breast carcinomas and lymph node metastases

   • E. Müller-Holzner
   • A. G. Zeimet
   • O. Dapunt

   Report Pages: 47 - 55

7. Toremifene and tamoxifen in advanced breast cancer - a double-blind cross-over trial

   • Lars E. Stenbygaard
   • Jørn Herrstedt
   • Per Dombernowsky

   Report Pages: 57 - 63

8. Growth and metastasis of human breast carcinomas with Matrigel in athymic mice

   • Rajeshwari R. Mehta
   • Jewell M. Graves
   • Tapas K. Gupta

   Report Pages: 65 - 71

9. Structural and functional studies of insulin receptors in human breast cancer

   • Lucia Frittitta
   • Riccardo Vigneri
   • Vincenzo Trischitta

   Report Pages: 73 - 82

10. Toward a molecular understanding of human breast cancer: A hypothesis

    • Jerry W. Shay
    • Woodring E. Wright
    • Harold Werbin

    Hypotheses Pages: 83 - 94